All articles by Joshua Silverwood

Can more investment save the NHS from failing technology?

In the weeks and months since Keir Starmer’s government took the reins in the UK, promises have been made as…
MHRA calls for industry input on keeping EU law, IVD classification & more

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has launched a consultation period calling on the public and private…
MED-EL bags expanded clearances for hearables system

North Carolina-based hearables company, MED-EL Corporation, has secured clearance from the US Food and Drug Administration (FDA) for a range…
Vivolta teams up with Neurochase to manufacture electrospun micro-catheters

Netherlands-based medical electrospinning company Vivolta has signed a long-term partnership with UK company Neurochase to manufacture micro-catheters thatdeliver advanced therapies…
Momentis Surgical secures FDA clearance for gynaecological surgical robot

Florida-based robotic surgery firm, Momentis Surgical, has announced that its second-generation surgical gynaecology robot equipped with miniature humanoid-shaped robotic arms,…

Lunit AI diagnostic SCOPE system cuts disease progression by 51%

South Korean artificial intelligence (AI) company Lunit has revealed results from a trial of its system ability to predict immunotherapy…
Harbinger Health partners with New York clinic on cancer blood trials

Massachusetts-based company, Harbinger Health has struck a partnership with New York hospital, Memorial Sloan Kettering Cancer Center (MSK), to advance…
Parallel Fluidics reels in $7m to drive microfluidics manufacturing

Boston-based microfluidic device manufacturer, Parallel Fluidics, has secured $7m in seed funding. The funds will be used to develop the…
Chung-Ang University develops new non-invasive CKD test

Researchers at Seoul’s Chung-Ang University have developed a new, non-invasive method form of biosensor designed for the early detection of…
Philips enrols first patient in pivotal PAD trial

Dutch medtech giant Philips has announced that it has enrolled the first patient in its THOR IDE clinical trial set…